RETRACTION: Cryptotanshinone Inhibits RANKL-induced Osteoclastogenesis by Regulating ERK and NF-κB Signaling Pathways

RETRACTION: W. Wang, M. Huang, Y. Hui, P. Yuan, X. Guo, and K. Wang, “Cryptotanshinone Inhibits RANKL-induced Osteoclastogenesis by Regulating ERK and NF-κB Signaling Pathways,” Journal of Cellular Biochemistry 120, no. 5 (2019): 7333-7340, https://doi.org/10.1002/jcb.28008.

The above article, published online on 2 December 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Christian Behl; and Wiley Periodicals LLC. The retraction has been agreed due to concerns raised by third parties on the data presented in the article. Specifically, several image elements in Figure 1 C were found to have been sourced from a previously published article by a different author group and inappropriately edited. Finally, inappropriate post-acquisition splicing has been detected in the Western Blot experiment depicted in Figure 5 A. The article has been retracted as the editors have lost trust in the overall accuracy of the presented data, and consider the conclusions to be invalid. The authors agree with the decision of retraction and apologize for any inconvenience caused.